Ye, Minhui
Fang, Yingzhe
Chen, Lu
Song, Zemin
Bao, Qing
Wang, Fei
Huang, Hao
Xu, Jin
Wang, Ziwen http://orcid.org/0000-0002-1678-7624
Xiao, Ruijing
Han, Meng
Gao, Song http://orcid.org/0000-0001-7427-6681
Liu, Hudan http://orcid.org/0000-0003-1362-6048
Jiang, Baishan http://orcid.org/0000-0001-6796-9500
Qing, Guoliang http://orcid.org/0000-0002-7892-2860
Funding for this research was provided by:
National Natural Science Foundation of China (82230092, 81830084)
Article History
Received: 20 June 2023
Accepted: 28 February 2024
First Online: 16 March 2024
Competing interests
: M.Y., Y.F., L.C., B.J. and G.Q. are inventors on a patent application in China related to therapeutic targeting of NUDT1 in treatment of MYC(N)-driven cancers (202311783418.X). The key findings regarding synthetic lethality between NUDT1 inhibition and MYC(N) activation as well as NUDT1-targeting molecules disclosed in this manuscript are a subject of patent application filed by Wuhan University. All remaining authors declare no competing interests.